Leyla DEPRET-BIXIO

As a RWR manager, Leyla has the mission to guarantee high quality, timely, real world data generation to fill medical and epidemiological needs, to accelerate and maintain access in order that patients benefit of our medicines.
This is accomplished through our professionalism and expertise on Non Interventional Research studies.

Ensure study design, methods, and analytics fully meet scientific standards and requirements.
• Provide methodological and statistical expertise to design and conduct of Non-interventional studies (NIR), Epidemiological studies, ATU (expanded access program) ,ISR-NIR (Sponsor Investigator Research) and ensure scientific quality from conception of the study to publication.
• Provide methodological and statistical expertise to design and conduct studies requested by French Health Authorities in collaboration with HEOR ( Health Economics Outcome Research).
• Collaborate with Market Access Strategy, to help increase the value of our medicines, contribute to the preparation of Health technology assessment (HTA) evaluation and strengthen the qualitative aspect of filings for all therapeutic areas (Oncology, Cardiology, Immuno-science, Pain and virology (HIV and hepatitis C)).
• Provide estimates of the budget for Post Marketing Studies, Epidemiological studies and Non Interventional studies.
• Manage a team of 5 people ( Statisticians and Pharmaco Epidemio Senior Project Leader)
• Others activities :
o Collaborate with the French Customer Experience Program. Leyla is an ambassador leading a working group on “How to better share BMS’ information to our customers”.
o Working on the conception and governance of a new process to track NIR studies and budget for NIR. This new process has been envisioned in order to facilitate tracking and speed the communication process. This is important to measure our budget activity and study status.